Founded in 2015 by Franck Le Ouay, co -founder of Criteo, and Alexandre Huckert, the startup Lifen celebrates its tenth anniversary this year. In a decade, the company has taken several structuring stages to become a central player in the digitization of the French health system. In 2025, it announced the profitability of its historic activity, Lifen Care, and reached an annual recurrent turnover of 20 million euros. An increase made possible by a development strategy based on the industrialization of medical data flows nationally.
Lifen first concentrated his efforts on the fluidification of communication between health professionals. His first brick, Lifen Documents, allows you to send in one click medical reports via secure channels (MSSANTE, APICRYPT or MAY), while integrating documents into shared medical file (DMP). Deployed in more than 800 establishments, the solution has established itself as an operational standard in hospitals and clinical, public and private. Each month, more than 4 million documents pass through the platform, 95 % of which are dematerialized.
On this basis, the company has developed a second brick, Lifen Integration. This solution makes it possible to make the integration of documents into the incorporation of computerized files (DPI), with automatic validation of patient identity, a structuring of key information (document type, date of the act, stay) and a contextualized classification. In 2024, more than 5 million documents were integrated into the DPIs automatically or semi-automated. The promise is to simplify the tasks of administrative and medical teams, while strengthening identity and completeness of the files.
Lifen is based on a documentary artificial intelligence, trained on more than 75 million medical documents. Each day, more than a million predictions are produced in real time, making it possible to extract data useful for integration, sending or clinical research. “” “Our AI was designed to meet a field need: detect, structure and secure the information contained in medical documents. It is continuously fed by real flows and enriched by medical validations”Said Franck Le Ouay during the last AI for Health Summit.
In 2023, Lifen crossed a new step by launching Lifen Datalab, an infrastructure intended to facilitate multicentric clinical research projects. This solution allows establishments to constitute cohorts of patients from DPIs, automatically structure data of interest via AI, and to access a continuous updated base. “” “If we want to add a variable because we wonder about its relevance to characterize a particular type of cancer, the tool will be able to go and rescue all the reports and extract it. It is an incroyabl powerE ”, explains Professor Benjamin Besse, director of clinical research in Gustave Roussy.
On a high structuring healthtech chessboard, Lifen adopts a resolutely infrastructural approach. While Doctolib has imposed itself on uses on the office (appointment, teleconsultation), or thatOwkin Develops predictive models applied to biomedical research, Lifen focuses on the background: circulation, structuring and reliability of medical data within hospital information systems. On some technical aspects, she meets group offers like Dedalus (via Maincare or Orbis), or Enovacomwhich also offer interoperability or mssanté messaging bricks. But unlike these publishers, Lifen does not provide a complete hospital system and integrates into existing environments via a modular and interoperable model.
To support these developments, Lifen has lifted almost 80 million euros in four laps, including a series C of 50 million euros in 2021 with Creadev and Lauxera Capital Partnerswith the renewed support of its historic investors Parthi, Serena and the Macsf. The startup is also supported by the program France 2030
Lifen today claims an extended national network, collaborating with the main private groups (Elsan, Ramsay, Vivalto, Almaviva) as well as with 14 CHUs and cancer control centers. Three first research cohorts were structured with partner establishments, including Lucc (in collaboration with Gustave Roussy), Harpe (CHU Grenoble Alpes) and Cub Trajectory (Foch Hospital), aimed at including 10,000 patients with chronic respiratory pathologies by the end of 2025.
